d-alpha tocopherol has been researched along with ropivacaine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Braga, Ade F; Brunetto, GB; Cereda, CM; de Araujo, DR; de Oliveira, AL; de Paula, E; Fraceto, LF; Neto, HS; Pierucci, A; Vomero, VU | 1 |
| Casadei, BR; Cereda, CM; Couto, VM; da Silva, CM; de Paula, E; Fraceto, LF; Franz-Montan, M | 1 |
| Chao, L; Liu, Y; Qiu, D; Yang, Y | 1 |
3 other study(ies) available for d-alpha tocopherol and ropivacaine
| Article | Year |
|---|---|
Pharmacological and local toxicity studies of a liposomal formulation for the novel local anaesthetic ropivacaine.
Topics: alpha-Tocopherol; Amides; Anesthetics, Local; Animals; Cholesterol; Drug Evaluation, Preclinical; Eggs; Liposomes; Male; Mice; Nerve Block; Particle Size; Pharmaceutical Solutions; Phosphatidylcholines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Ropivacaine; Schwann Cells; Toxicity Tests | 2008 |
Development of egg PC/cholesterol/α-tocopherol liposomes with ionic gradients to deliver ropivacaine.
Topics: alpha-Tocopherol; Amides; Cholesterol; Chromatography, High Pressure Liquid; Drug Delivery Systems; Eggs; Ions; Liposomes; Phosphatidylcholines; Ropivacaine | 2016 |
Topical anesthetic analgesic therapy using the combination of ropivacaine and dexmedetomidine: hyaluronic acid modified long-acting nanostructured lipid carriers containing a skin penetration enhancer.
Topics: Administration, Cutaneous; Analgesics; Anesthetics, Local; Animals; BALB 3T3 Cells; Dexmedetomidine; Drug Carriers; Drug Liberation; Hyaluronic Acid; Lipids; Mice; Nanoparticles; Nanostructures; Particle Size; Phosphatidylethanolamines; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Ropivacaine; Skin Absorption; Vitamin E | 2019 |